首页> 外文期刊>Biomaterials >Photo-crosslinkable, injectable sericin hydrogel as 3D biomimetic extracellular matrix for minimally invasive repairing cartilage
【24h】

Photo-crosslinkable, injectable sericin hydrogel as 3D biomimetic extracellular matrix for minimally invasive repairing cartilage

机译:作为3D仿生细胞外基质的光交联,可注射胺水凝胶,用于微创修复软骨

获取原文
获取原文并翻译 | 示例
       

摘要

Millions of patients worldwide suffer from cartilage injury and age/disease-related cartilage degeneration. However, cartilage, such as articular cartilage, is poor at self-regeneration. Current treatments are often invasive with limited efficacy. Developing minimal invasive strategies for effective cartilage repair is highly desired. Here, we report an injectable, photo-crosslinkable sericin hydrogel as a biomimetic extracellular matrix for minimal invasively repairing cartilage. Sericin was functionalized to be sericin methacryloyl (SerMA), which formed an in situ hydrogel upon UV light irradiation via photo-crosslinking. Possessing excellent biocompatibility, SerMA hydrogels were adhesive to chondrocytes, and promoted the proliferation of attached chondrocytes even in a nutrition-lacking condition. SerMA hydrogels exhibited photoluminescent property allowing real-time monitoring hydrogels' status. The mechanical properties and degradation rates (73% for SMH-1, 47% for SMH-2 and 37% for SMH-3 after 45 days) of SerMA hydrogels were readily tunable by varying methacryloyl modification degrees to meet various repair requirements. Notably, the in vivo implantation of chondrocyte-laden SerMA hydrogels effectively formed artificial cartilages after 8 weeks. Most importantly, the artificial cartilages molecularly resembled native cartilage as evidenced by high accumulation of cartilage-specific ECM components and upregulated expression of cartilage-critical genes. Together, this sericin hydrogel is a promising tissue engineering scaffold for generating artificial cartilage in vivo towards effective, minimal invasive cartilage repair. (C) 2018 Elsevier Ltd. All rights reserved.
机译:全球数百万患者患有软骨损伤和年龄/疾病相关的软骨变性。然而,软骨,如关节软骨,在自我再生时差。目前的治疗通常具有有限的有效性侵入性。强烈需要开发最小的有效软骨修复的侵入性策略。在这里,我们报告可注射的光交联的霉素水凝胶作为仿生细胞外基质,用于最小的侵入性修复软骨。硅蛋白被官能化为胺甲基丙烯酰基(SERMA),其通过光交联在UV光照射时形成原位水凝胶。具有优异的生物相容性,Serma水凝胶对软骨细胞粘附,即使在营养缺乏状态下也促进了附着的软骨细胞的增殖。 Serma水凝胶表现出光致发光性,允许实时监测水凝胶的状态。通过改变甲基丙烯酰基改性度,易于调谐机械性能和降解速率(SMH-1,SMH-2的SMH-2和37%的SMH-3,47%,SMH-3,SMH-3的37%),以满足各种修复要求。值得注意的是,在8周后有效地形成了软骨细胞 - 升起的细胞血清水凝胶的体内植入。最重要的是,人工软骨分子类似于天然软骨,其高积累的软骨特异性ECM组分证明以及软骨 - 临界基因的上调表达。这种硅蛋白水凝胶在一起是一个有前途的组织工程支架,用于在体内产生人造软骨,朝向有效,最小的侵入式软骨修复。 (c)2018年elestvier有限公司保留所有权利。

著录项

  • 来源
    《Biomaterials》 |2018年第2018期|共16页
  • 作者单位

    Huazhong Univ Sci &

    Technol Tongji Med Coll Union Hosp Res Ctr Tissue Engn &

    Regenerat Med;

    Huazhong Univ Sci &

    Technol Tongji Med Coll Union Hosp Res Ctr Tissue Engn &

    Regenerat Med;

    Huazhong Univ Sci &

    Technol Tongji Med Coll Union Hosp Dept Respirat Wuhan 430022 Hubei;

    Huazhong Univ Sci &

    Technol Tongji Med Coll Union Hosp Res Ctr Tissue Engn &

    Regenerat Med;

    Huazhong Univ Sci &

    Technol Tongji Med Coll Union Hosp Dept Gastrointestinal Surg Wuhan 430022;

    Huazhong Univ Sci &

    Technol Tongji Med Coll Union Hosp Res Ctr Tissue Engn &

    Regenerat Med;

    Huazhong Univ Sci &

    Technol Tongji Med Coll Union Hosp Res Ctr Tissue Engn &

    Regenerat Med;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物医学工程;
  • 关键词

    Sericin; Cartilage tissue engineering; Photo-crosslinking; Hydrogel;

    机译:霉菌;软骨组织工程;光交联;水凝胶;
  • 入库时间 2022-08-20 15:54:37

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号